Mandeg, Michell T.
HRN: 11-48-98 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/30/2022
CEFUROXIME 1.5GM (VIAL)
07/30/2022
07/31/2022
IVT
1.5gm
Q8H X 3 Doses
S/P NSVD; UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractReproductive Tract Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes